Position
Creative Planning in Mirum Pharmaceuticals, Inc.
Back to the book · All holders of MIRM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $410.5K$78.99 → $92.38
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 31.5K | $2.49M | — | — | — | 0.0% |
| Q1 2026 | 30.7K | $2.83M | $92.38 | $410.5K | −$68.2K | 0.0% |